OpenAI is acquiring startup Orchestra Bio and plans to merge it with its life sciences AI platform Rosalind. The goal is to build AI agents that help pharma teams coordinate drug development, from tracking trials to spo…
Capital flows signal where the market expects the next advantage, and often precede pricing and capacity changes.
Companies and models mentioned in this story — open their pages and live prices
Summaries are aggregated for information only — follow the source link for the full story. Demo entries are illustrative.